Učitavanje...
Cancer stem cells in neuroblastoma therapy resistance
Neuroblastoma (NB) is the most common cancer of infancy and accounts for nearly one tenth of pediatric cancer deaths. This mortality rate has been attributed to the > 50% frequency of relapse despite intensive, multimodal clinical therapy in patients with progressive NB. Given the disease’s heter...
Spremljeno u:
| Izdano u: | Cancer Drug Resist |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
OAE Publishing Inc.
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924637/ https://ncbi.nlm.nih.gov/pubmed/31867574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.72 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|